How does anticoagulant therapy influence outcomes in patients undergoing extracorporeal photopheresis, and what clinical adjustments are necessary?
Gaurav ChauhanContributor
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does anticoagulant therapy influence outcomes in patients undergoing extracorporeal photopheresis, and what clinical adjustments are necessary?
Anticoagulant therapy during extracorporeal photopheresis (ECP) helps prevent clot formation in the circuit but requires careful monitoring to balance bleeding risks. Adjusting the anticoagulant dose based on patient-specific factors and coagulation tests is crucial for safety and efficacy.